SoloVir Electrokinetic Transdermal System: Phase II data

In the double-blind, placebo-controlled Phase II TPI-H-221 trial in about 260 patients with recurrent herpes labialis, SoloVir ETS missed primary endpoint of superiority vs. placebo in the duration of...